Abstract
Human T cell leukemia viruses (HTLVs) are complex human retroviruses of the Deltaretrovirus genus. Four types have been identified thus far, with HTLV-1 and HTLV-2 much more prevalent than HTLV-3 or HTLV-4. HTLV-1 and HTLV-2 possess strictly related genomic structures, but differ significantly in pathogenicity, as HTLV-1 is the causative agent of adult T cell leukemia and of HTLV-associated myelopathy/tropical spastic paraparesis, whereas HTLV-2 is not associated with neoplasia. HTLVs code for a protein named Tax that is responsible for enhancing viral expression and drives cell transformation. Much effort has been invested to dissect the impact of Tax on signal transduction pathways and to identify functional differences between the HTLV Tax proteins that may explain the distinct oncogenic potential of HTLV-1 and HTLV-2. This review summarizes our current knowledge of Tax-1 and Tax-2 with emphasis on their structure, role in activation of the NF-κB (nuclear factor kappa-B) pathway, and interactions with host factors.
INTRODUCTION
The Human T cell leukemia viruses (HTLVs) are complex retroviruses, belonging to the primate T-lymphotropic virus (PTLV) family. HTLVs are classified as Deltaretroviruses, together with bovine leukemia virus (BLV) and simian T-lymphotropic viruses (STLVs). HTLV-1 was originally described in 1980 (Poiesz et al., 1980) and was the first oncogenic retrovirus discovered in humans (reviewed by ; ). HTLVs originated in Africa around 30,000–40,000 years ago through cross-species transmission of STLVs from monkeys to man. The virus evolved to HTLV and spread to different geographic regions with human migration (Van Dooren et al., 2001). STLVs with high homology to HTLVs are still present in Africa (). HTLVs are transmitted both vertically and horizontally (reviewed in Watanabe, 2011; Yasunaga and Matsuoka, 2011; ) but cell-to-cell transmission is essential and occurs through direct contact through the formation of a virological synapse (; ; ).
HTLV-1 has received much scientific attention due to its ability to transform primary human T-lymphocytes in cell culture and its association with a neoplasia and a neuropathology (). The most important HTLV-1-associated diseases are the adult T cell leukemia (ATL), a very aggressive form of leukemia, and the HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP), a neurological demyelinating disease (Osame et al., 1986; ; Yoshida, 2010; ; Yamagishi and Watanabe, 2012). Three additional genotypes of HTLV, named HTLV-2, HTLV-3, and HTLV-4, have been isolated and characterized, with HTLV-2 the most common after HTLV-1 (; ). Although HTLVs share a similar genomic structure, HTLV-2 is much less pathogenic than HTLV-1 since it does not cause neoplastic disorders and is sporadically associated with cases of subacute myelopathy (). Understanding the molecular basis of the different pathogenicity of HTLV-1 and HTLV-2 may thus provide important clues to the molecular mechanisms of cancer. All HTLVs possess an open reading frame (ORF) encoding the Tax transactivator, which is essential for proviral gene expression from the viral long terminal repeat (LTR) promoter and also regulates the expression and function of a number of cellular genes and proteins (; Wycuff and Marriott, 2005; ; ). Tax alone is capable of modulating several pathways by activating the transcription factors nuclear factor kappa-B (NF-κB) and cyclic AMP responsive binding protein (CREB; ; Tang et al., 2013a). Tax also interacts with proteins controlling cell cycle checkpoints (; ). HTLV-1 Tax (Tax-1) is necessary and sufficient for T cell immortalization () and an ATL-like syndrome has been observed in transgenic mice expressing Tax in the T cell compartment (Ohsugi, 2013). It is noteworthy to mention that in ATL patients, Tax expression is silenced in about 50% of the patients. This observation, along with the fact that Tax is capable of transforming primary T lymphocytes in vitro, suggests that Tax might be important for establishing the leukemic phenotype of ATL, but may become dispensable for its maintenance. In addition, recent studies suggest that other viral gene products may play relevant roles in HTLV-1-mediated transformation and may be responsible of the different HTLV-1 and HTLV-2 pathogenicity, including the antisense HTLV-1 genome transcript HBZ (; ; Satou and Matsuoka, 2012; Zhao and Matsuoka, 2012), the HTLV-1 accessory protein p12 () and p13 (Silic-Benussi et al., 2010a, b).
Tax-1 has been very extensively studied and its interactome includes more than 100 proteins (for a recent review see ). To further clarify this point and to better understand the reasons for the difference in pathogenicity between HTLV-1 and HTLV-2 as well as from other HTLVs, in this review we have focused on the structural and functional properties of the different Tax proteins and their relations with other viral and cellular factors. The following sections highlight recent advances in the comprehension of: (i) the transformation potential of Tax-1, Tax-2, Tax-3, and Tax-4 proteins; (ii) Tax’s role in the deregulation of signal transduction focusing on studies which describe novel interactions of Tax proteins with host factors and contribute to the understanding of the molecular mechanisms of cell response to viral infection; and (iii) Tax-mediated activation of the NF-κB pathway focusing on differences between Tax-1 and Tax-2 involvement in canonical and non-canonical pathways.
SPECIFIC FEATURES OF DIFFERENT HTLV GENOTYPES
Following the discovery of HTLV-1 in 1980, three additional HTLVs were found: HTLV-2 in 1982 (; Vandamme, 2000; ) and HTLV-3 and HTLV-4 in 2005 (; Wolfe et al., 2005). These four genotypes show specific geographical areas of distribution. HTLV-1, which includes seven subtypes (HTLV-1A to -1G), is endemic in Japan, sub-Saharan Africa, South America, the Caribbean Islands, and Melanesia. About 5–10 million people worldwide are infected with HTLV-1, most of whom are expected to remain asymptomatic throughout their lifetime (). An estimated 2–5% of infected people develop clinical complications including ATL, HAM/TSP, infective dermatitis, uveitis, arthritis, and infection by Strongyloides stercoralis (). HTLV-2, for which the four subtypes -2A to -2D are known, is endemic within the Amerindian and Pygmy populations, and was found to be epidemic in intravenous drug users (). In contrast to HTLV-1, HTLV-2 does not cause proliferative blood diseases. However, HTLV-2 has been linked to neurological disorders, arthritis, pneumonia, and with increased mortality (; Roucoux and Murphy, 2004; ). The two new genotypes, termed HTLV-3 and HTLV-4, were discovered in asymptomatic individuals from Cameroon (; Wolfe et al., 2005); the pathogenic potential of these viruses is still unknown. HTLV-3 is closely related to the simian virus STLV-3, whereas an STLV corresponding to HTLV-4 has not yet been found (Sintasath et al., 2009).
Comparative studies of the genomic sequences of all four HTLV genotypes have highlighted common as well as unique molecular features. HTLV-1 and HTLV-2 have a similar genomic structure and share approximately 70% nucleotide sequence homology (). HTLV-3 and HTLV-4 have a genomic organization which is similar to that of HTLV-1 and HTLV-2 with the presence of gag, pro, pol, and env ORFs as well as of tax and rex, whereas ORFs for auxiliary proteins still need to be confirmed (; Figure 1). HTLV-3 shares about 62% identity with HTLV-1 and HTLV-4 shares 62–71% nucleotide similarity with HTLV-1, HTLV-2, and HTLV-3 (Switzer et al., 2006). HTLV-3 and HTLV-4 present LTRs that lack the distal 21 bp transcription regulatory repeat sequence (Switzer et al., 2006). Both HTLV-3 and HTLV-4 present on the antisense strand a potential ORF named APH-3 and APH-4, respectively (antisense protein of HTLV), analogous to the HBZ gene of HTLV-1 () and APH-2 of HTLV-2 (). Sequence alignment indicated that APH-3 and APH-4 are more closely related to APH-2 than to HBZ (). The proteins also present some differences, as APH-2, APH-3, and APH-4 do not contain a consensus bZIP (basic leucine zipper) domain present in HBZ, and differ in their subcellular localization as compared to HBZ (; ).
FIGURE 1
COMPARISON OF Tax PROTEINS STRUCTURES
The tax gene is encoded within the pX region of HTLV, located between env and the 3′-LTR, and is highly conserved among all four genotypes and different subtypes of the virus (). The Tax protein is common to all primate members of the PTLVfamily. The primary amino acids (aa) sequence of Tax-1 is composed of 353 residues, and is organized into functional domains that have been extensively investigated (; ). The structural and functional domains of Tax-1, Tax-2, Tax-3, and Tax-4 are shown in Figure 2. The N-terminal region of Tax-1 contains a CREB-binding region (Yin et al., 1995) that spans aa 1–60. This region is involved in the interaction with ATF/CREB transcription factors and represents a binding domain required for interaction with proteins involved in transcription, cell cycle progression, and cell signaling regulation (Suzuki et al., 1993a; ). All Tax proteins contain the CREB-binding domain within their N-terminus. A nuclear localization signal (NLS) is located within the first 60 aa in Tax-1 (Smith and Greene, 1992), Tax-3 and Tax-4 (; Switzer et al., 2009). A nuclear localization determinant (NLD) is present within the first 42 aa in Tax-2 (Sheehy et al., 2006; Turci et al., 2006a). An additional localization domain is attributed to Tax-2 at aa position 90–100, which confers to the protein a more abundant accumulation into the cytoplasm as compared to Tax-1 (). All four Tax proteins contain a conserved region representing a nuclear export sequence (NES) that has been functionally characterized in both Tax-1 and Tax-2 and is located at aa position 189–202 in Tax-1 (; ). Two leucine zipper-like motif regions (LZRs) are present at aa 116–145 and 213–248 in Tax-1 and conserved in Tax-2, Tax-3, and Tax-4 as well. These regions are required for protein dimerization and binding of cellular factors (; ). Tax-1 and Tax-3 are characterized by the presence of a PDZ-binding motif (PBM) at the C-terminal region () whereas this is missing in Tax-2 and Tax-4. This domain is required for interactions between Tax-1 and cellular factors such as the tumor suppressors hDlg, MAGI-1, and Scribble and the synapse-associated protein DlgI (Rousset et al., 1998; Suzuki et al., 1999; Okajima et al., 2008; Yoshida et al., 2008; ). The absence of the PDZ domain renders Tax-2 unable to interact with these factors. The four subtypes of HTLV-2 (-2A to -2D) code for similar but not identical Tax proteins. Tax-2A is composed of 331 aa and is shorter than Tax-2B, Tax-2C, and Tax-2D (356, 356, and 344 aa, respectively; ), Tax-2B is the variant that has been studied in greatest detail (). Tax-1 and Tax-2B share 85% aa similarity, whereas Tax-3 displays 26 and 30% divergence with respect to Tax-1 and Tax-2, respectively. The comparison of Tax-4 with Tax-1, Tax-2, and Tax-3 shows 83, 91, and 85% aa similarity, respectively (Switzer et al., 2009), as outlined in Figure 3. The main characteristic that distinguishes Tax-1 from Tax-2 is the presence only in Tax-1 of a motif spanning aa 225–232 that activates the non-canonical NF-κB pathway through interaction with the p100 factor (Shoji et al., 2009). A second relevant difference between Tax-1 and Tax-2 is the presence in Tax-1, but not in Tax-2, of the PBM at the C-terminus (; ; Rende et al., 2012). Based on sequence homology, all the Tax proteins possess two functional regions involved in CBP (CREB-binding protein)/p300 binding: a KID-like domain between residues 81 and 95 and a second domain named C-terminal transcriptional activating CR2 domain, between aa 312 and 319. These domains present some differences between Tax-1, Tax-2, Tax-3, and Tax-4. One of the major differences is related to the lysine residue at position 85, which is necessary for Tax-1 to bind CBP/p300 (); this residue is substituted by an arginine in Tax-2, Tax-3, and Tax-4 (; ).
FIGURE 2
FIGURE 3
Post-translational modifications of Tax-1 and Tax-2 such as phosphorylation, acetylation, ubiquitination, and sumoylation have been extensively described in recent reviews (; ; ). Recent comparative analyses of Tax-1 and Tax-2 post-translational modifications centered on the contribution of ubiquitination and sumoylation to the intracellular localization of Tax and its ability to activate NF-κB (; ; ; Turci et al., 2009, 2012; ; Xiao, 2012; Zane and Jeang, 2012; ). These studies highlighted the role of specific lysines as targets for sumoylation and ubiquitination in Tax-1 and Tax-2 (lysines K1 to K10 in Tax-1, see Figure 2). Lysines K6 and K8 are critical for NF-κB activation and are highly conserved in all Tax proteins. Additional lysines, indicated by additional roman numbers, are present in Tax-2 (K2i, K3i, K3ii, and K10i, Figure 2) whereas Tax-3 and Tax-4 contain 11 and 10 lysines, respectively, but not all are conserved at the same position. Alignment of the predicted Tax-4 sequence shows the absence of K10, which is a target of acetylation in Tax-1 and possibly in Tax-2 (; ).
Tax is generally defined as a multifunctional protein, since it is able to activate both viral and host gene transcription and to act as mediator of several cellular pathways. Of particular importance was the demonstration that Tax-1 is able to immortalize and transform human primary CD4+ T cells (; ; Yoshida, 2001) and the finding that Tax-1-transgenic mice develop ATL (; Ohsugi, 2013). It is well-established that Tax-1 plays a relevant role in the oncogenesis induced by HTLV infection. Tax-1 acts as a pleiotropic protein conferring proliferative and survival properties to HTLV-1 – infected cells by modulating regulatory factors that induce cell proliferation, cell cycle progression, inhibition of apoptosis, and interference with DNA repair. The main factors include CREB, CBP/p300, NF-κB, cyclin-dependent kinases (CDKs), and Akt (reviewed by ; ).
TRANSFORMATION POTENTIAL OF Tax PROTEINS
Tax-1 is able to transform T-lymphocytes and fibroblasts and to induce tumors in transgenic mice (; ; ; Ohsugi, 2013). The ability to transform primary human T cells was also demonstrated for Tax-2 (Ross et al., 1996; ). Both proteins are able to inhibit the function of the tumor suppressor p53. A comparative study between Tax-1 and Tax-2 subtypes demonstrated that Tax-2A inhibits p53 function less efficiently than Tax-1 or Tax-2B (). Although several in vitro studies have investigated the ability of Tax to inactivate p53 (Tabakin-Fix et al., 2006) by acting on the CREB or NF-κB pathway, the mechanism of this inhibition has not yet been completely clarified. A recent study by Zane et al. (2012) identified a cooperative role for the cellular factor Wip1 (wild-type p53-induced phosphatase 1) in Tax-1-mediated inactivation of p53; a subsequent study demonstrated interactions between Tax-1 and Wip1 (). In a study that employed transgenic mice expressing Tax-1 which develop mature T cell leukemia and lymphoma, Ohsugi et al. (2013) demonstrated that Tax-1 alters p53 function and that this effect precedes NF-κB activation.
Tax-2 transforms rat fibroblasts less efficiently than Tax-1 (). On the other hand, both viruses immortalizes primary human T cells at a comparable efficiency (). demonstrated that the non-canonical NF-κB factor p100 and the PBM present in Tax-1, but not in Tax-2, are essential for the transformation of a T cell. Tsubata et al. (2005) had already shown that the PBM domain is critical for the ability of Tax-1 to induce interleukin-2 (IL-2)-independent growth of the IL-2-dependent T cell line CTLL-2, and that Tax-2 lacks this ability. Xie et al. (2006) showed that the deletion of the PBM in a recombinant HTLV-1 molecular clone (HTLV-1/ΔPBM) alters the requirement for the establishment and maintenance of persistent infection in rabbits. A motif responsible for the distinct transforming activity of Tax-1 and Tax-2 was identified by using a series of Tax-1/Tax-2 chimeric proteins. A region corresponding to aa 225–232 of Tax-1 was shown to play a crucial role in Tax-1’s transforming activity, involving stimulation of the non-canonical NF-κB/p100 pathway (Shoji et al., 2009). recently demonstrated that Tax-2B can immortalize human CD4+ T cells. By infecting peripheral blood mononuclear cells (PBMCs) with lentiviruses encoding Tax-1 or Tax-2B they observed a higher immortalization activity of Tax-2B as compared to Tax-1.
Studies of Tax-2-immortalized T cells demonstrated that Tax-2 causes a dysregulation of autophagy; this may represent a novel survival mechanism in Tax-2-immortalized T cells (Ren et al., 2012). A similar action was attributed to Tax-1, thus suggesting that autophagy may play an important role in the HTLV life cycle (Tang et al., 2013b). Tax-3 was shown to be able to activate the NF-κB pathway and bind CBP in the T cell line CEM, thus suggesting that Tax-3 has in vitro transforming activity (). The transforming properties of Tax-4 remain to be investigated.
Tax AND SIGNAL TRANSDUCTION DEREGULATION
The role of Tax in HTLV-1-induced oncogenesis has been investigated in large part by analyzing the capacity of Tax-1 to interact with selected cellular factors that play a crucial role in signaling pathways. A list of Tax-interacting proteins is presented in Table 1. Tax-1 expression deregulates several signaling pathways involved in the cell cycle, cell proliferation, and cell survival, primarily through the deregulation of two major cellular transcription factor pathways: CREB/ATF and NF-κB (Sun and Yamaoka, 2005; ). Tax-1 constitutively activates NF-κB by causing a deregulated expression of a variety of cellular genes. Tax-dependent NF-κB activation has been extensively studied and the current state of knowledge will be described in the next section. Tax-1 activation through the cellular transcription factor CREB has been well-characterized at the level of the HTLV-1 promoter located in the LTR region. Within the HTLV-1 promoter three conserved 21 bp repeat enhancer elements called viral CRE elements (vCRE) are present that can be recognized within a complex containing Tax-1 and a phosphorylated form of CREB. The Tax/CREB/vCREB complexes can be associated to other host factors. The best characterized are the cellular coactivators CBP and p300 (), which stimulate Tax-mediated transactivation by chromatin remodeling (). In addition, Tax-1 interacts with the SWI/SNF chromatin remodeling complexes () and may be involved in the nucleosome eviction activity mediated by the nucleosome assembly protein 1 (NAP1; Sharma and Nyborg, 2008). Additional host factors that directly interact with Tax-1 and act in the Tax-mediated transactivation are the transducer of regulated CREB (TORC) proteins. TORC-1 and TORC-2 are required for Tax activation whereas TORC-3 enhances Tax-dependent transcription (; Siu et al., 2006). Several cellular factors that interact with Tax and participate to HTLV-1 promoter activation have been identified. The transcriptional activator CIITA affects the functional interaction of the transcription factors CREB, ATF1, and PCAF with Tax-1 (Tosi et al., 2011) and Tax-2 activation of HTLV-2 LTR is strongly inhibited by CIITA (Orlandi et al., 2011). Recently, Tang et al. (2013a) demonstrated that the LKB1 tumor suppressor and the salt inducible kinases (SIKs) act as negative regulatory factors in the activation of HTLV-1 LTR by Tax. They showed that LKB1 and SIK interact with Tax and that this association enables LTR activation by TORCs, CREB, and Tax-1 (Tang et al., 2013a). Additional cellular mediators of Tax-induced activation of HTLV-1 LTR belong to the group I p21-activated kinases (Paks) which physically interact with Tax and CREB-regulating transcriptional coactivators to facilitate HTLV-1 transcription ().
Table 1
| Pathways | Factors | Reference |
|---|---|---|
| G proteins | Gβ subunit | Twizere etal. (2007) |
| Rho GTPases | Wu etal. (2004) | |
| MAPKs | MEKK1 | Yin etal. (1998) |
| TAK1 | Wu and Sun (2007) | |
| JNK | GPS2 | |
| AP1 | p85α | Peloponese and Jeang (2006) |
| TGFβ | Smad2 | |
| Smad3 | ||
| Smad4 | ||
| NF-κB | IKKα | Chu et al. (1998) |
| IKKβ | ||
| IKKγ/NEMO | ||
| IkBα | Suzuki etal. (1995) | |
| IkBγ | ||
| RelA | Suzuki etal. (1994) | |
| p100 | ||
| p50 | Suzuki etal. (1993b) | |
| TAK | Wu and Sun (2007) | |
| TRAF6 | ||
| NRP/optineurin | ||
| USP20 | Yasunaga etal. (2011) | |
| TAX1BP1 | ||
| CREB | CBP/p300 | |
| CREM | Suzuki etal. (1993a) | |
| ATF-4 | Reddy etal. (1997) | |
| XBP-1 | ||
| TORC | ||
| LKB1 | Tang etal. (2013a) | |
| SIK1 | Tang etal. (2013b) | |
| Paks | ||
| CIITA | Tosi etal. (2011) | |
| SW1/SNF | PBAF | |
| HDAC | CBP/p300 | |
| Histone modification | CARM1/SMYD3 | Yamamoto etal. (2011) |
| SRF | SRF | |
| Elk-1 | Shuh and Derse (2000) | |
| SAP-1 | ||
| Microtubule formation | TAB2 | Yu etal. (2008) |
| hsMAD1/TXBP181 | ||
| Tax1BP2 | ||
| G1/S transition | Cdk4 | |
| Cdk6 | ||
| DNA repair | DNA-PK | |
| ATM | ||
| CHK2 | ||
| Wip1 | ||
| PI3K/Akt1 signaling | Beclin1 | |
| PI3KC3 | ||
| Tumor suppression | MAGI-1 | |
| Scribble | Okajima etal. (2008) | |
| hDlg | Suzuki etal. (1999) |
Tax-1 interacting proteins and deregulated pathways.
The role of Tax-1 in the expression of cellular genes containing CRE elements was demonstrated for several genes involved in cell cycle and proliferation. Recently demonstrated that Tax-1 deregulates cyclin D1 gene expression thus determining its overexpression. The mechanism requires an enhanced binding between p300 and phosphorylated CREB and TORC-2. The interaction of Tax-1 with CREB/ATF factors also represses the expression of several genes, including cyclin A (), p53 (), c-myc (Semmes et al., 1996a), and the ZNF268 gene, whichplays a role in the differentiation of blood cells during development and in the pathogenesis of leukemia (Wang et al., 2008).
The main functional and structural differences between Tax-1, Tax-2, and Tax-3 are presented in Table 2. It is evident that the Tax proteins differ not only in their transformation abilities, structural properties, and protein interactions, as described in the previous sections, but also in additional aspects of cellular interactions. Tax-2 is distributed both in the nucleus and in the cytoplasm, showing a more diffuse distribution in the cytoplasm compared to Tax-1 (Turci et al., 2009). We have recently demonstrated that Tax-1 and Tax-2 colocalize with TAB2-containing cytoplasmic structures that include RelA and calreticulin (). Compared to Tax-1, Tax-2 differs in post-transcriptional modification () and we have shown that, in transfected cells, lysine usage for sumoylation differs between Tax-1 and Tax-2 (Turci et al., 2012). When compared to Tax-1, Tax-2 is less efficient in the induction of micronuclei formation (Semmes et al., 1996b), is unable to suppress multilineage hematopoiesis from CD34+ cells in vitro (Tripp et al., 2003) and to direct the lipid raft translocation of IκB kinase alpha (IKKα) and IKKβ in transfected cells and in Tax-2-immortalized primary T cells ().
Table 2
| Tax-1 | Tax-2a | Tax-3 | Reference | |
|---|---|---|---|---|
| Transactivating activity | Highera | Lowerb | n.d.c | Semmes etal. (1996a) |
| Transformation capacity | Higher | Lower | n.d. | |
| Micronuclei formation | + | - | n.d. | Semmes etal. (1996b) |
| Cell cycle arrest | + | - | n.d. | Tripp etal. (2005) |
| Hematopoiesis suppression | + | - | n.d. | Tripp etal. (2003) |
| Reduction of histone gene expression | + | - | n.d. | ; |
| Inhibition of p53 functions | Higher | Lower | + | ;,; |
| Total viral mRNA expression | Higher | Lower | n.d. | |
| Proinflammatory cytokine expression | Higher | Lower | n.d. | |
| Presence of PDZ motif | + | - | n.d. | |
| Interaction with PDZ-binding proteins | + | - | + | |
| Interaction with p100 | + | - | n.d. | Shoji etal. (2009) |
| Preferential cellular localization | Nucleus | Cytoplasm | n.d. | Turci etal. (2009) |
| NF-κB transactivation | + | + | + | |
| NF-κB transactivation (lipid raft translocation of IKK) | + | - | n.d. | |
| In vitro CK2 phosphorylation | + | - | n.d. | |
| Oligo-sumoylation | + | - | n.d. | Turci etal. (2009) |
| Nuclear bodies | Larger | Smaller | n.d. | Turci etal. (2009) |
| Ubiquitination and sumoylation | + | + | n.d. | Turci etal. (2012);Zane etal. (2012) |
| Nuclear localization | + | + | + | |
| T cell immortalization | + | + | + | ; |
Summary of main functional and structural differences between Tax-1, Tax-2, and Tax-3.
The properties of Tax-2 include those described for Tax-2A and/or Tax-2B reported in the literature.
Higher and lower refers to a comparison between Tax-1 and Tax-2.
n.d.: not determined.
Recent reports have investigated the different role of Tax-1 and Tax-2 in innate immunity. We have previously demonstrated that HIV-1/HTLV-2 coinfection in drug users is associated to a delayed progression of AIDS (Turci et al., 2006b). CC-chemokines are produced spontaneously by T lymphocytes of HIV-1/HTLV-2 coinfected subjects (). Recently, it has been demonstrated that Tax-1 and Tax-2 induce the expression of the CC-chemokines MIP1-α/CCL 3 MIP-1β/CCL4, and RANTES/CCL5 and that downregulate CCR5 in monocytes and PBMCs (; ). Furthermore, a significant decrease of HIV-1 replication has been reported in cultures of PMBCs infected by HIV-1 and treated with Tax-1 or Tax-2 (). In this in vitro cell system the effect of Tax-2 on HIV-1 replication is higher than that of Tax-1 and the authors suggest that Tax-2 may act as an immunomodulatory protein during HTLV-2 infection.
An emerging role in HTLV-1 pathogenesis is attributed to the antisense protein HBZ which contains a bZIP motif, required to form heterodimers with cellular transcription factors. HBZ inhibits viral and cellular expression by interacting with CREB and additional transcription factors and, in contrast to Tax-1, is consistently expressed in ATL cells (). Compared to HTLV-1, HTLV-2 expresses an antisense protein named APH-2, which is structurally different from HBZ, lacking the classical bZIP domain. APH-2 is able to interact with CREB and to repress the activation of HTLV-2 gene expression mediated by Tax-2 (). A recent study has shown that APH-2 may interact with Tax-2 and when co-expressed with Tax-2, impairs the ability of Tax-2 to activate AP-1 transcription (). AP-1 pathway involves several factors, including Jun, Fos, Maf, and ATF that act on cell proliferation, apoptosis, and oncogenic transformation (Shaulian and Karin, 2001). The distinct structural and functional diversities of HBZ and APH-2 and their interactions with Tax proteins may be relevant for the different pathogenicity of HTLV-1 and HTLV-2 and the mechanisms need to be further investigated.
Tax AND THE NF-κB PATHWAY
Enhanced NF-κB activation is one of the principal consequences of the expression of Tax in the infected cells. The NF-κB family of inducible transcription factors regulate diverse biological processes, including the growth and survival of both T cells and non-lymphoid cells. Activation of NF-κB transcription factors occurs through two tightly controlled signaling processes known as the canonical and non-canonical NF-κB pathways. The principal activators and regulators of these two pathways are illustrated in Figure 4. The canonical pathway is activated by different receptor signals including inflammatory cytokines, genotoxic stress, antigens, and toll like receptors (TLRs), whereas the activation of the non-canonical pathway involves signaling molecules that are recognized only by a specific subset of tumor necrosis factor receptors (TNFRs), such as lymphotoxin-β, BAFF, RANKL, and TWEAK (Sun, 2011). The NF-κB transcription factors family includes five members: RelA/p65, c-Rel, RelB, p50, and p52. The p50 and p52 proteins are expressed as precursor proteins named p105 and p100, respectively. The processing of these precursors to mature forms requires proteasome activity. The five members form dimers with one another and can bind to a variety of target DNA sequences called κB sites to modulate gene expression. p50 and p52 can activate transcription by forming heterodimers with RelA/p65, c-Rel, or RelB. In the cytoplasm, the NF-κB complexes are inactive since they are bound to inhibitory IκB proteins (IκBα, IκBβ, IκB∊, etc.). Activation of the pathway requires IκB protein degradation and translocation of NF-κB dimers to the nucleus. The common step of activation is mediated by the IKK complex, which phosphorylates IκB and targets it to proteosomal degradation. The IKK complex consists of two active kinases, IKKα and IKKβ, and the regulatory scaffolding protein NEMO (IKKγ). Tax directly interacts with these factors, leading to a persistent activation of NF-κB-mediated transcription. Tax-1 stimulates the activation of both the canonical and non-canonical NF-κB pathway thought the interaction with the IKK factors; the Tax/IKKγ interaction is required for recruiting Tax to the IKK catalytic subunits and for Tax-mediated IKK activation (Sun and Yamaoka, 2005).
FIGURE 4
Other cellular proteins are important for Tax-mediated NF-κB activation. Tax-1 interacts with NRP/optineurin and TAX1BP1 (; Shembade et al., 2011), and with the ubiquitin-specific peptidase USP20 (Yasunaga et al., 2011). A recent study demonstrated that Tax-1 promotes Bcl-3 expression and nuclear translocation of RelA/p65 (). provided evidence that Tax-1 induces Bcl-3 expression primarily through activation of the NF-κB pathway. Another recent study has demonstrated that Tax-1 transactivates CD69, a marker of early activation of lymphocytes, through both NF-κB and CREB signaling pathways ().
Tax-1-mediated activation of the non-canonical NF-κB pathway is important in virus-induced tumorigenesis. A region of Tax-1 spanning aa 225–232 is essential for activation of the non-canonical pathway. In contrast to Tax-1, Tax-2 is not able to activate the non-canonical pathway and does not interact with or induce processing of p100 into p52 (; Shoji et al., 2009). Furthermore, Tax-2 has been demonstrated to not be able to interact with TRAF6, a protein with E3 ligase activity that, in the presence of Tax-1, positively regulates the activation of NF-κB pathway ().
Ubiquitination and sumoylation of Tax-1 and Tax-2 are involved in NF-κB activation (; ; ; Turci et al., 2009, 2012; ). Both Tax proteins co-immunoprecipitate and colocalize with IKKγ/NEMO, TAB2, and RelA/p65 in transfected cells (; Sun and Yamaoka, 2005; ). Expression of Tax proteins induces IKKα and RelA/p65 nuclear translocation (; ). An overactivation of NF-κB by Tax induces cellular senescence (Zhi et al., 2011). By knockdown experiments, demonstrated that chronic activation of NF-κB by Tax-1 results in rapid senescence (Tax-induced rapid senescence, Tax-IRS) that is dependent on IKKα and p65/RelA activation. The Tax-IRS phenomenon constitutes a host checkpoint response to the overactivation of NF-κB that prevents cellular transformation (Zhi et al., 2011; ) and represents an interesting mechanism of host cell protection from the deregulating activities of viral proteins.
CONCLUSION
HTLV-1 and HTLV-2 can efficiently transform T-lymphocytes, but only HTLV-1 causes ATL. Although additional viral products play important roles in the HTLV pathogenesis, Tax represents a key factor in the early stage of T cell oncogenesis. In this review we have dissected the structural and functional features of the HTLV Tax proteins, focusing mainly on Tax-1 and Tax-2. These two proteins share many common properties including the capacity of transforming and immortalizing T cells, of transactivating NF-κB pathway and being modified by both ubiquitination and sumoylation. They significantly differ for the presence of a PDZ motif, which is missing in Tax-2, and for the activation of non-canonical NF-κB which is attributed only to Tax-1. The knowledge derived by studying Tax’s interactions with cellular factors and their effects on the induction of altered responses in cell pathway regulation confirms the complexity of HTLV oncogenesis. An interesting issue that needs to be explored in the future is the frequent downregulation of the expression of viral genes coded by the plus-strand (including Tax) in circulating leukemic cells from ATL patients. This phenomenon is likely due to epigenetic silencing of the plus-strand promoter, e.g., by methylation and/or expression of repressors of the Polycomb family (Satou and Matsuoka, 2012, 2013; Yamagishi and Watanabe, 2012). A pivotal mechanism that involves a circuit controlled signaling by miRNA has been recently demonstrated by Yamagishi et al. (2012) showing that miR-31 loss, in ATL primary cells, mediated by Polycomb-dependent epigenetic gene silencing, is associated to the overexpression of the NF-κB inducing kinase NIK and leads to constitutive activation of NF-κB oncogenic signaling.
It is likely that further studies aimed at dissecting the functional differences between the Tax proteins will reveal novel functions of host factors that are involved in the signal pathways altered in ATL and may become potential targets for effective therapies against leukemia.
The studies of the differences between Tax-1, Tax-2, Tax-3, and Tax-4 interacting cell factors and transactivating activities will provide useful information to the understating of Tax-1 structural transformation that may open a new approach on HTLV studies based on Tax-1 peculiarities and interactions with addition viral products, that are not present in HTLV-2, HTLV-3, and HTLV-4 Tax proteins.
Statements
Acknowledgments
We thank Donna D’Agostino for comments on the manuscript. This work was supported by AIRC (Associazione Italiana per la Ricerca sul Cancro) through a 2008 AIRC-Cariverona Regional grant (Maria G. Romanelli and Vincenzo Ciminale) and an AIRC Investigator Grant (Vincenzo Ciminale), by the University of Verona Joint project and by research funds to Maria G. Romanelli. Erica Diani was supported in part by an AIRC-Cariverona Regional fellowship.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
REFERENCES
1
AkagiT.OnoH.ShimotohnoK. (1995). Characterization of T cells immortalized by Tax1 of human T-cell leukemia virus type 1.Blood864243–4249.
2
AkagiT.OnoH.ShimotohnoK. (1996). Expression of cell-cycle regulatory genes in HTLV-I infected T-cell lines: possible involvement of Tax1 in the altered expression of cyclin D2, p18Ink4 and p21Waf1/Cip1/Sdi1.Oncogene121645–1652.
3
AlefantisT.BarmakK.HarhajE. W.GrantC.WigdahlB. (2003). Characterization of a nuclear export signal within the human T cell leukemia virus type I transactivator protein Tax.J. Biol. Chem.27821814–21822.10.1074/jbc.M211576200
4
AraujoA.HallW. W. (2004). Human T-lymphotropic virus type II and neurological disease.Ann. Neurol.5610–19.10.1002/ana.20126
5
AsquithB.ZhangY.MosleyA. J.de LaraC. M.WallaceD. L.WorthA. et al. (2007). In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection.Proc. Natl. Acad. Sci. U.S.A.1048035–8040.10.1073/pnas.0608832104
6
AvesaniF.RomanelliM. G.TurciM.Di GennaroG.SampaioC.BidoiaC. et al. (2010). Association of HTLV Tax proteins with TAK1-binding protein 2 and RelA in calreticulin-containing cytoplasmic structures participates in Tax-mediated NF-κB activation.Virology40839–48.10.1016/j.virol.2010.08.023
7
AzranI.Schavinsky-KhrapunskyY.AboudM. (2004). Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity.Retrovirology120 10.1186/1742-4690-1-20
8
BanghamC. R.OsameM. (2005). Cellular immune response to HTLV-1.Oncogene246035–6046.10.1038/sj.onc.1208970
9
BéraudC.SunS. C.GanchiP.BallardD. W.GreeneW. C. (1994). Human T-cell leukemia virus type I Tax associates with and is negatively regulated by the NF-kappa B2 p100 gene product: implications for viral latency.Mol. Cell. Biol.141374–1382.
10
BalistrieriG.BarriosC.CastilloL.UmunakweT. C.GiamC. Z.ZhiH. et al. (2013). Induction of CC-chemokines with antiviral function in macrophages by the human T lymphotropic virus type 2 transactivating protein, Tax2.Viral Immunol.263–12.10.1089/vim.2012.0060
11
BanerjeeP.RochfordR.AntelJ.CanuteG.WrzesinskiS.SieburgM. et al. (2007). Proinflammatory cytokine gene induction by human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 Tax in primary human glial cells.J. Virol.811690–1700.10.1128/JVI.01513-06
12
BarriosC. S.AbuerreishM.LairmoreM. D.CastilloL.GiamC. Z.BeilkeM. A. (2011). Recombinant human T-cell leukemia virus types 1 and 2 Tax proteins induce high levels of CC-chemokines and downregulate CBR5 in human peripheral blood mononuclear cells.Viral Immunol.24429–439. 10.1089/vim.2011.0037
13
BarriosC. S.CastilloL.GiamC. Z.WuL.BeilkeM. A. (2013). Inhibition of HIV type 1 replication by human T lymphotropic virus types 1 and 2 Tax proteins in vitro.AIDS Res. Hum. Retroviruses291061–1067.10.1089/aid.2013.0027
14
BasbousJ.BazarbachiA.GranierC.DevauxC.MesnardJ. M. (2003). The central region of human T-cell leukemia virus type 1 Tax protein contains distinct domains involved in subunit dimerization.J. Virol.7713028–13035.10.1128/JVI.77.24.13028-13035.2003
15
BertazzoniU.TurciM.AvesaniF.Di GennaroG.BidoiaC.RomanelliM. G. (2011). Intracellular localization and cellular factors interaction of HTLV-1 and HTLV-2 Tax proteins: similarities and functional differences.Viruses3541–560.10.3390/v3050541
16
BidoiaC.MazzoranaM.PaganoM. A.ArrigoniG.MeggioF.PinnaL. A. et al. (2010). The pleiotropic protein kinase CK2 phosphorylates HTLV-1 Tax protein in vitro, targeting its PDZ-binding motif.Virus Genes41149–157.10.1007/s11262-010-0494-3
17
BiswasH. H.KaidarovaZ.GarrattyG.GibbleJ. W.NewmanB. H.SmithJ. W.et al (2010). HTLV Outcomes Study.Increased all-cause and cancer mortality in HTLV-II infection. J. Acquir. Immune Defic. Syndr.54290–296.10.1097/QAI.0b013e3181cc5481
18
BonnetA.Randrianarison-HuetzV.NzounzaP.NedelecM.ChazalM.WaastL.et al (2012). Low nuclear body formation and tax SUMOylation do not prevent NF-kappaB promoter activation.Retrovirology977 10.1186/1742-4690-9-77
19
CalattiniS.ChevalierS. A.DuprezR.AfonsoP.FromentA.GessainA.et al (2006). Human T-cell lymphotropic virus type 3: complete nucleotide sequence and characterization of the human tax3 protein.J. Virol.809876–9888.10.1128/JVI.00799-06
20
CalattiniS.ChevalierS. A.DuprezR.BassotS.FromentA.MahieuxR.et al (2005). Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa.Retrovirology230 10.1186/1742-4690-2-30
21
ChanC. P.SiuY. T.KokK. H.ChingY. P.TangH. M.JinD. Y. (2013). Group I p21-activated kinases facilitate Tax-mediated transcriptional activation of the human T-cell leukemia virus type 1 long terminal repeats.Retrovirology1047 10.1186/1742-4690-10-47
22
ChengH.RenT.SunS. C. (2012). New insight into the oncogenic mechanism of the retroviral oncoprotein Tax.Protein Cell3581–589.10.1007/s13238-012-2047-0
23
ChevalierS. A.DurandS.DasguptaA.RadonovichM.CimarelliA.BradyJ. N.et al (2012). The transcription profile of Tax-3 is more similar to Tax-1 than Tax-2: insights into HTLV-3 potential leukemogenic properties.PLoS ONE7:e41003. 10.1371/journal.pone.0041003
24
ChevalierS. A.MeertensL.CalattiniS.GessainA.KiemerL.MahieuxR. (2005). Presence of a functional but dispensable nuclear export signal in the HTLV-2 Tax protein.Retrovirology27010.1186/1742-4690-2-70
25
ChevalierS. A.MeertensL.Pise-MasisonC.CalattiniS.ParkH.AlhajA. A.et al (2006). The tax protein from the primate T-cell lymphotropic virus type 3 is expressed in vivo and is functionally related to HTLV-1 Tax rather than HTLV-2 Tax.Oncogene254470–4482.10.1038/sj.onc.1209472
26
ChingY. P.ChanS. F.JeangK. T.JinD. Y. (2006). The retroviral oncoprotein Tax targets the coiled-coil centrosomal protein TAX1BP2 to induce centrosome overduplication.Nat. Cell Biol.8717–724.10.1038/ncb1432
27
ChlichliaK.KhazaieK. (2010). HTLV-1 Tax: linking transformation, DNA damage and apoptotic T-cell death.Chem. Biol. Interact.188359–365.10.1016/j.cbi.2010.06.005
28
ChuZ. L.DiDonatoJ. A.HawigerJ.BallardD. W. (1998). The tax oncoprotein of human T-cell leukemia virus type 1 associates with and persistently activates IkB kinases containing IKKα and IKKβ.J. Biol. Chem.27315891–15894.10.1074/jbc.273.26.15891
29
CurrerR.Van DuyneR.JaworskiE.GuendelI.SampeyG.DasR.et al (2012). HTLV tax: a fascinating multifunctional co-regulator of viral and cellular pathways.Front. Microbiol. 3:406. 10.3389/fmicb.2012.00406
30
DayaramT.LemoineF. J.DonehowerL. A.MarriottS. J. (2013). Activation of WIP1 phosphatase by HTLV-1 Tax mitigates the cellular response to DNA damage.PLoS ONE 8:e55989. 10.1371/journal.pone.0055989
31
DurkinS. S.GuoX.FryrearK. A.MihaylovaV. T.GuptaS. K.BelgnaouiS. M.et al (2008). HTLV-1 Tax oncoprotein subverts the cellular DNA damage response via binding to DNA-dependent protein kinase.J. Biol. Chem.28336311–36320.10.1074/jbc.M804931200
32
EasleyR.CarpioL.GuendelI.KlaseZ.ChoiS.Kehn-HallK.et al (2010). Human T-lymphotropic virus type 1 transcription and chromatin-remodeling complexes.J. Virol.844755–4768.10.1128/JVI.00851-09
33
EgoT.AriumiY.ShimotohnoK. (2002). The interaction of HTLV-1 Tax with HDAC1 negatively regulates the viral gene expression.Oncogene217241–7246.10.1038/sj.onc.1205701
34
EndoK.HirataA.IwaiK.SakuraiM.FukushiM.OieM.et al (2002). Human T-cell leukemia virus type 2 (HTLV-2) Tax protein transforms a rat fibroblast cell line but less efficiently than HTLV-1 Tax.J. Virol.762648–2653.10.1128/JVI.76.6.2648-2653.2002
35
FeuerG.GreenP. L. (2005). Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2.Oncogene245996–6004.10.1038/sj.onc.1208971
36
FranchiniG. (1995). Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection.Blood863619–3639.
37
FujiiM.TsuchiyaH.ChuhjoT.AkizawaT.SeikiM. (1992). Interaction of HTLV-1 Tax1 with p67SRF causes the aberrant induction of cellular immediate early genes through CArG boxes.Genes Dev.62066–2076.10.1101/gad.6.11.2066
38
GalloR. C. (2002). Human retroviruses after 20 years: a perspective from the past and prospects for their future control.Immunol. Rev.185236–265.10.1034/j.1600-065X.2002.18520.x
39
GalloR. C. (2011). Research and discovery of the first human cancer virus, HTLV-1.Best Pract. Res. Clin. Haematol.24559–565.10.1016/j.beha.2011.09.012
40
GaoC.WangX.ChenL.WangJ. H.GaoZ. T.WangH. (2013). Knockdown of Bcl-3 inhibits cell growth and induces DNA damage in HTLV-1-infected cells.Asian Pac. J. Cancer Prev.14405–408.10.7314/APJCP.2013.14.1.405
41
GessainA.CassarO. (2012). Epidemiological aspects and world distribution of HTLV-1 infection.Front. Microbiol.3:388. 10.3389/fmicb.2012.00388
42
GessainA.MahieuxR. (2012). Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.Rev. Neurol. (Paris)168257–269.10.1016/j.neurol.2011.12.006
43
GessainA.RuaR.BetsemE.TurpinJ.MahieuxR. (2013). HTLV-3/4 and simian foamy retroviruses in humans: discovery, epidemiology, cross-species transmission and molecular virology.Virology435187–199.10.1016/j.virol.2012.09.035
44
GonçalvesD. U.ProiettiF. A.RibasJ. G.AraújoM. G.PinheiroS. R.GuedesA. C.et al (2010). Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases.Clin. Microbiol. Rev.23577–589.10.1128/CMR.00063-09
45
GorenI.SemmesO. J.JeangK. T.MoellingK. (1995). The amino terminus of Tax is required for interaction with the cyclic AMP response element binding protein.J. Virol.695806–5811.
46
GrassmannR.BerchtoldS.RadantI.AltM.FleckensteinB.SodroskiJ. G.et al (1992). Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture.J. Virol.664570–4575.
47
HajjH. E.NasrR.KfouryY.DassoukiZ.NasserR.KchourG.et al (2012). Animal models on HTLV-1 and related viruses: what did we learn?Front. Microbiol.3:333. 10.3389/fmicb.2012.00333
48
HalinM.DouceronE.ClercI.JournoC.KoN. L.LandryS.et al (2009). Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription.Blood1142427–2438.10.1182/blood-2008-09-179879
49
HallerK.WuY.DerowE.SchmittI.JeangK. T.GrassmannR. (2002). Physical interaction of human T-cell leukemia virus type 1 Tax with cyclin-dependent kinase 4 stimulates the phosphorylation of retinoblastoma protein.Mol. Cell. Biol.223327–3338.10.1128/MCB.22.10.3327-3338.2002
50
HarhajE. W.SunS. C. (1999). IKKgamma serves as a docking subunit of the IkappaB kinase (IKK) and mediates interaction of IKK with the human T-cell leukemia virus Tax protein.J. Biol. Chem.27422911–22914.10.1074/jbc.274.33.22911
51
HarrodR.KuoY. L.TangY.YaoY.VassilevA.NakataniY.et al (2000). P300 and p300/camp-responsive element-binding protein associated factor interact with human T-cell lymphotropic virus type-1 Tax in a multi-histone acetyltransferase/activator-enhancer complex.J. Biol. Chem.27511852–11857.10.1074/jbc.275.16.11852
52
HasegawaH.SawaH.LewisM. J.OrbaY.SheehyN.YamamotoY.et al (2006). Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I.Nat. Med.12466–472.10.1038/nm1389
53
HiguchiM.FujiiM. (2009). Distinct functions of HTLV-1 Tax1 from HTLV-2 tax2 contribute key roles to viral pathogenesis.Retrovirology6117 10.1186/1742-4690-6-117
54
HiguchiM.TsubataC.KondoR.YoshidaS.TakahashiM.OieM.et al (2007). Cooperation of NF-kappaB2/p100 activation and the PDZ domain binding motif signal in human T-cell leukemia virus type 1 (HTLV-1) Tax1 but not HTLV-2 Tax2 is crucial for interleukin-2-independent growth transformation of a T-cell line.J. Virol.8111900–11907.10.1128/JVI.00532-07
55
HiraiH.SuzukiT.FujisawaJ.InoueJ.YoshidaM. (1994). Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor kappa B and induces nuclear translocation of transcription factor NF-κB proteins for transcriptional activation.Proc. Natl. Acad. Sci. U.S.A.913584–3588.10.1073/pnas.91.9.3584
56
HiramatsuK.YoshikuraH. (1986). Frequent partial deletion of human adult T-cell leukemia virus type I proviruses in experimental transmission: pattern and possible implication.J. Virol.58508–512.
57
HoY. K.ZhiH.DeBiasoD.PhilipS.ShihH. M.GiamC. Z. (2012). HTLV-1 tax-induced rapid senescence is driven by the transcriptional activity of NF-κB and depends on chronically activated IKKα and p65/RelA.J. Virol.869474–9483.10.1128/JVI.00158-12
58
HuangJ.RenT.GuanH.JiangY.ChengH. (2009). HTLV-1 Tax is a critical lipid raft modulator that hijacks IkappaB kinases to the microdomains for persistent activation of NF-kappaB.J. Biol. Chem.2846208–6217.10.1074/jbc.M806390200
59
ImaiM.HiguchiM.KawamuraH.YoshitaM.TakahashiM.OieM.et al (2013). Human T cell leukemia virus type 2 (HTLV-2) Tax2 has a dominant activity over HTLV-1 Tax1 to immortalize human CD4+ T cells.Virus Genes4639–46.10.1007/s11262-012-0831-9
60
IshikawaC.KawakamiH.UchiharaJ. N.SenbaM.MoriN. (2013). CD69 overexpression by human T-cell leukemia virus type 1 Tax transactivation.Biochim. Biophys. Acta18331542–1552.10.1016/j.bbamcr.2013.03.006
61
JeongS. J.Pise-MasisonC. A.RadonovichM. F.ParkH. U.BradyJ. N. (2005). Activated AKT regulates NF-kB activation, p53 inhibition and cell survival in HTLV-1-transformed cells.Oncogene246719–6728.10.1038/sj.onc.1208825
62
JinD. Y.JeangK. T. (1997). Transcriptional activation and self-association in yeast: protein-protein dimerization as a pleiotropic mechanism of HTLV-I Tax function.Leukemia 11(Suppl.3)3–6.
63
JinD. Y.SpencerF.JeangK. T. (1998). Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1.Cell9381–91.10.1016/S0092-8674(00)81148-4
64
JinD. Y.TeramotoH.GiamC. Z.ChunR. F.GutkindJ. S.JeangK. T. (1997). A human suppressor of c-Jun N-terminal kinase 1 activation by tumor necrosis factor alpha.J. Biol. Chem.27225816–25823.10.1074/jbc.272.41.25816
65
JournoC.BonnetA.Favre-BonvinA.TurpinJ.VineraJ.CôtéE.et al. (2013). Human T cell leukemia virus type 2 tax-mediated NF-κB activation involves a mechanism independent of Tax conjugation to ubiquitin and SUMO.J. Virol.871123–1136.10.1128/JVI.01792-12
66
JournoC.FilipeJ.AboutF.ChevalierS. A.AfonsoP. V.BradyJ. N.et al (2009). NRP/optineurin Cooperates with TAX1BP1 to potentiate the activation of NF-kappaB by human T-lymphotropic virus type 1 tax protein.PLoS Pathog.5:e1000521. 10.1371/journal.ppat.1000521
67
KalyanaramanV. S.SarngadharanM. G.Robert-GuroffM.MiyoshiI.GoldeD.GalloR. C. (1982). A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia.Science218571–573.10.1126/science.6981847
68
KannianP.GreenP. L. (2010). Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis.Viruses22037–2077.10.3390/v2092037
69
KashanchiF.BradyJ. N. (2005). Transcriptional and post-transcriptional gene regulation of HTLV-1.Oncogene245938–5951.10.1038/sj.onc.1208973
70
KfouryA. G.StehlikJ.RenlundD. G.SnowG.SeamanJ. T.GilbertE. M.et al (2006). Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patterns.J. Heart Lung Transplant.251277–1282.10.1016/j.healun.2006.08.009
71
KfouryY.NasrR.JournoC.MahieuxR.PiqueC.BazarbachiA. (2012). The multifaceted oncoprotein Tax: subcellular localization, posttranslational modifications, and NF-κB activation.Adv. Cancer Res.11385–120.10.1016/B978-0-12-394280-7.00003-8
72
KiblerK. V.JeangK. T. (2001). CREB/ATF-dependent repression of cyclin A by human T-cell leukemia virus type 1 Tax protein.J. Virol.752161–2173.10.1128/JVI.75.5.2161-2173.2001
73
KimY. M.GeigerT. R.EganD. I.SharmaN.NyborgJ. K. (2010). The HTLV-1 tax protein cooperates with phosphorylated CREB, TORC2 and p300 to activate CRE-dependent cyclin D1 transcription.Oncogene292142–2152.10.1038/onc.2009.498
74
KimY. M.SharmaN.NyborgJ. K. (2008). The proto-oncogene Bcl3, induced by Tax, represses Tax-mediated transcription via p300 disment from the human T-cell leukemia virus type 1 promoter.J. Virol.8211939–11947.10.1128/JVI.01356-08
75
KogaH.OhshimaT.ShimotohnoK. (2004). Enhanced activation of tax-dependent transcription of human T-cell leukemia virus type I (HTLV-I) long terminal repeat by TORC3.J. Biol. Chem.27952978–52983.10.1074/jbc.M409021200
76
KuS. C.LeeJ.LauJ.GurumurthyM.NgR.LwaS. H.et al (2008). XBP-1, a novel human T-lymphotropic virus type 1 (HTLV-1) tax binding protein, activates HTLV-1 basal and tax-activated transcription.J. Virol.824343–4353.10.1128/JVI.02054-07
77
KwokR. P.LauranceM. E.LundbladJ. R.GoldmanP. S.ShihH.ConnorL. M.et al (1996). Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP.Nature380642–646.10.1038/380642a0
78
LairmoreM. D.HainesR.AnupamR. (2012). Mechanisms of human T-lymphotropic virus type 1 transmission and disease.Curr. Opin. Virol.2474–481.10.1016/j.coviro.2012.06.007
79
LamsoulI.LodewickJ.LebrunS.BrasseurR.BurnyA.GaynorR. B.et al (2005). Exclusive ubiquitination and sumoylation on overlapping lysine residues mediate NF-kappaB activation by the human T-cell leukemia virus tax oncoprotein.Mol. Cell. Biol.2510391–10406.10.1128/MCB.25.23.10391-10406.2005
80
Larocqueé.HalinM.LandryS.MarriottS. J.SwitzerW. M.BarbeauB. (2011). Human T-cell lymphotropic virus type 3 (HTLV-3)- and HTLV-4-derived antisense transcripts encode proteins with similar Tax-inhibiting functions but distinct subcellular localization.J. Virol.8512673–12685.10.1128/JVI.05296-11
81
LewisM. J.GautierV. W.WangX. P.KaplanM. H.HallW. W. (2000). Spontaneous production of C-C chemokines by individuals infected with human T lymphotropic virus type II (HTLV-II) alone and HTLV-II/HIV-1 coinfected individuals.J. Immunol.1654127–4132.
82
LiM.GreenP. L. (2007). Detection and quantitation of HTLV-1 and HTLV-2 mRNA species by real-time RT-PCR.J. Virol. Methods142159–168.10.1016/j.jviromet.2007.01.023
83
LodewickJ.LamsoulI.BexF. (2011). Move or die: the fate of the Tax oncoprotein of HTLV-1.Viruses3829–857.10.3390/v3060829
84
LodewickJ.LamsoulI.PolaniaA.LebrunS.BurnyA.RatnerL.et al (2009). Acetylation of the human T-cell leukemia virus type 1 Tax oncoprotein by p300 promotes activation of the NF-kappaB pathway.Virology38668–78.10.1016/j.virol.2008.12.043
85
MahieuxR.GessainA. (2009). The human HTLV-3 and HTLV-4 retroviruses: new members of the HTLV family.Pathol. Biol. (Paris)57161–166.10.1016/j.patbio.2008.02.015
86
MahieuxR.Pise-MasisonC. A.LambertP. F.NicotC.De MarchisL.GessainA.et al (2000). Differences in the ability of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 tax to inhibit p53 function.J. Virol.746866–6874.10.1128/JVI.74.15.6866-6874.2000
87
MajorovitsE.NejmeddineM.TanakaY.TaylorG. P.FullerS. D.BanghamC. R. (2008). Human T-lymphotropic virus-1 visualized at the virological synapse by electron tomography.PLoS ONE3:e2251. 10.1371/journal.pone.0002251
88
MakokhaG. N.TakahashiM.HiguchiM.SaitoS.TanakaY.FujiiM. (2013). Human T-cell leukemia virus type 1 Tax protein interacts with and mislocalizes the PDZ domain protein MAGI-1.Cancer Sci.104313–320.10.1111/cas.12087
89
MannsA.BlattnerW. A. (1991). The epidemiology of the human T-cell lymphotrophic virus type I and II: etiologic role in human diseases.Transfusion3167–75.10.1046/j.1537-2995.1991.31191096189.x
90
MarbanC.McCabeA.BukongT. N.HallW. W.SheehyN. (2012). Interplay between the HTLV-2 Tax and APH-2 proteins in the regulation of the AP-1 pathway.Retrovirology998 10.1186/1742-4690-9-98
91
MatsuokaM.GreenP. L. (2009). The HBZ gene, a key player in HTLV-1 pathogenesis.Retrovirology671 10.1186/1742-4690-6-71
92
MatsuokaM.JeangK. T. (2007). Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation.Nat. Rev. Cancer7270–280.10.1038/nrc2111
93
MatsuokaM.JeangK. T. (2011). Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy.Oncogene301379–1389.10.1038/onc.2010.537
94
MeertensL.ChevalierS.WeilR.GessainA.MahieuxR. (2004a). A 10-amino acid domain within human T-cell leukemia virus type 1 and type 2 Tax protein sequences is responsible for their divergent subcellular distribution.J. Biol. Chem.27943307–43320.10.1074/jbc.M400497200
95
MeertensL.Pise-MasisonC.QuereN.BradyJ.GessainA.MahieuxR. (2004b). Utilization of the CBP but not the p300 co-activator by human T-lymphotropic virus type-2 Tax for p53 inhibition.Oncogene235447–5458.10.1038/sj.onc.1207719
96
MoriN.MorishitaM.TsukazakiT.GiamC. Z.KumatoriA.TanakaY.et al (2001). Human T-cell leukemia virus type i oncoprotein Tax represses Smad-dependent transforming growth factor beta signaling through interaction with CREB-binding protein/p300.Blood972137–2144.10.1182/blood.V97.7.2137
97
MulloyJ. C.KislyakovaT.CeresetoA.CasaretoL.LoMonicoA.FullenJ.et al (1998). Human T-cell lymphotropic/leukemia virus type 1 Tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB/ATF functional domain.J. Virol.728852–8860.
98
NasrR.ChiariE.El SabbanM.MahieuxR.KfouryY.AbdulhayM.et al (2006). Tax ubiquitylation and sumoylation control critical cytoplasmic and nuclear steps of NF-kappa B activation.Blood1074021–4029.10.1182/blood-2005-09-3572
99
NejmeddineM.BarnardA. L.TanakaY.TaylorG. PBanghamC. R. (2005). Human T-lymphotropic virus, type 1, tax protein triggers microtubule reorientation in the virological synapse.J. Biol. Chem.28029653–29660.10.1074/jbc.M502639200
100
NyborgJ. K.EganD.SharmaN. (2010). The HTLV-1 Tax protein: revealing mechanisms of transcriptional activation through histone acetylation and nucleosome disassembly.Biochim. Biophys. Acta1799266–274.10.1016/j.bbagrm.2009.09.002
101
OhsugiT. (2013). A transgenic mouse model of human T cell leukemia virus type 1-associated diseases.Front. Microbiol. 4:49. 10.3389/fmicb.2013.00049
102
OhsugiT.IshidaT.ShimasakiT.OkadaS.UmezawaK. (2013). p53 dysfunction precedes the activation of nuclear factor-κB during disease progression in mice expressing Tax, a human T-cell leukemia virus type 1 oncoprotein.Carcinogenesis 10.1093/carcin/bgt144[Epub ahead of print].
103
OkajimaM.TakahashiM.HiguchiM.OhsawaT.YoshidaS.YoshidaY.et al (2008). Human T-cell leukemia virus type 1 Tax induces an aberrant clustering of the tumor suppressor Scribble through the PDZ domain-binding motif dependent and independent interaction.Virus Genes37231–240.10.1007/s11262-008-0259-4
104
OrlandiC.ForlaniG.TosiG.AccollaR. S. (2011). Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication.J. Transl. Med.9106 10.1186/1479-5876-9-106
105
OsameM.UsukuK.IzumoS.IjichiN.AmitaniH.IgataA.et al (1986). HTLV-I associated myelopathy, a new clinical entity.Lancet11031–1032.10.1016/S0140-6736(86)91298-5
106
PeloponeseJ. M. Jr., JeangK. T. (2006). Role for Akt/protein kinase B and activator protein-1 in cellular proliferation induced by the human T-cell leukemia virus type 1 tax oncoprotein.J. Biol. Chem.2818927–8938.10.1074/jbc.M510598200
107
PoieszB. J.RuscettiF. W.GazdarA. F.BunnP. A.MinnaJ. D.GalloR. C. (1980). Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.Proc. Natl. Acad. Sci. U.S.A.777415–7419.10.1073/pnas.77.12.7415
108
ReddyT. R.TangH.LiX.Wong-StaalF. (1997). Functional interaction of the HTLV-1 transactivator Tax with activating transcription factor-4 (ATF4).Oncogene142785–2792.10.1038/sj.onc.1201119
109
RenT.DongW.TakahashiY.XiangD.YuanY.LiuX.et al (2012). HTLV-2 Tax immortalizes human CD4+ memory T lymphocytes by oncogenic activation and dysregulation of autophagy.J. Biol. Chem.28734683–34693.10.1074/jbc.M112.377143
110
RendeF.CavallariI.RomanelliM. G.DianiE.BertazzoniU.CiminaleV. (2012). Comparison of the genetic organization, expression strategies and oncogenic potential of HTLV-1 and HTLV-2.Leuk. Res. Treatment.2012876153 10.1155/2012/876153
111
RossT. M.PettifordS. M.GreenP. L. (1996). The tax gene of human T-cell leukemia virus type 2 is essential for transformation of human T lymphocytes.J. Virol.705194–5202.
112
RoucouxD. F.MurphyE. L. (2004). The epidemiology and disease outcomes of human T-lymphotropic virus type II.AIDS Rev.6144–154.
113
RoussetR.FabreS.DesboisC.BantigniesF.JalinotP. (1998). The C-terminus of the HTLV-1 Tax oncoprotein mediates interaction with the PDZ domain of cellular proteins.Oncogene16643–654.10.1038/sj.onc.1201567
114
SatouY.MatsuokaM. (2012). Molecular and cellular mechanism of leukemogenesis of ATL: emergent evidence of a significant role for HBZ in HTLV-1-induced pathogenesis.Leuk. Res. Treatment201221365310.1155/2012/213653
115
SatouY.MatsuokaM. (2013). Virological and immunological mechanisms in the pathogenesis of human T-cell leukemia virus type 1.Rev. Med. Virol.23269–280. 10.1002/rmv.1745
116
SemmesO. J.BarrettJ. F.DangC. V.JeangK. T. (1996a). Human T-cell leukemia virus type I Tax masks c-myc function through a cAMP-dependent pathway.J. Biol. Chem.2719730–9738.10.1074/jbc.271.16.9730
117
SemmesO. J.MajoneF.CantemirC.TurchettoL.HjelleB.JeangK. T. (1996b). HTLV-I and HTLV-II Tax: differences in induction of micronuclei in cells and transcriptional activation of viral LTRs.Virology217373–379.10.1006/viro.1996.0126
118
SharmaN.NyborgJ. K. (2008). The coactivators CBP/p300 and the histone chaperone NAP1 promote transcription-independent nucleosome eviction at the HTLV-1 promoter.Proc. Natl. Acad. Sci. U.S.A.1057959–7963.10.1073/pnas.0800534105
119
ShaulianE.KarinM. (2001). AP-1 in cell proliferation and survival.Oncogene202390–2400.
120
SheehyN.LillisL.WattersK.LewisM.GautierV.HallW. (2006). Functional analysis of human T lymphotropic virus type 2 Tax proteins.Retrovirology320 10.1186/1742-4690-3-20
121
ShembadeN.PujariR.HarhajN. S.AbbottD. W.HarhajE. W. (2011). The kinase IKKα inhibits activation of the transcription factor NF-κB by phosphorylating the regulatory molecule TAX1BP1.Nat. Immunol.12834–843.10.1038/ni.2066
122
ShojiT.HiguchiM.KondoR.TakahashiM.OieM.TanakaY.et al (2009). Identification of a novel motif responsible for the distinctive transforming activity of human T-cell leukemia virus (HTLV) type 1 Tax1 protein from HTLV-2 Tax2.Retrovirology683 10.1186/1742-4690-6-83
123
ShuhM.DerseD. (2000). Ternary complex factors and cofactors are essential for human T-cell leukemia virus type 1 tax transactivation of the serum response element.J. Virol.7411394–11397.10.1128/JVI.74.23.11394-11397.2000
124
Silic-BenussiM.CavallariI.VajenteN.VidaliS.Chieco-BianchiL.Di LisaF.et al (2010a). Redox regulation of T-cell turnover by the p13 protein of human T-cell leukemia virus type 1: distinct effects in primary versus transformed cells.Blood11654–62.10.1182/blood-2009-07-235861
125
Silic-BenussiM.BiasiottoR.AndresenV.FranchiniG.D’AgostinoD. M.CiminaleV. (2010b). HTLV-1 p13, a small protein with a busy agenda.Mol. Aspects Med.31350–358.10.1016/j.mam.2010.03.001
126
SintasathD. M.WolfeN. D.LebretonM.JiaH.GarciaA. D.Le Doux-DiffoJ.et al (2009). Simian T-lymphotropic virus diversity among nonhuman primates, Cameroon.Emerg. Infect. Dis.15175–184. 10.3201/eid1502.080584
127
SiuY. T.ChinK. T.SiuK. L.Yee Wai ChoyE.JeangK. T.JinD. Y. (2006). TORC1 and TORC2 coactivators are required for tax activation of the human T-cell leukemia virus type 1 long terminal repeats.J. Virol.807052–7059.10.1128/JVI.00103-06
128
SmithM. R.GreeneW. C. (1992). Characterization of a novel nuclear localization signal in the HTLV-I tax transactivator protein.Virology187316–320.10.1016/0042-6822(92)90320-O
129
SunS. (2011). Non-canonical NF-kB signalling pathway.Cell Res.2171–85.10.1038/cr.2010.177
130
SunS. C.YamaokaS. (2005). Activation of NF-kappaB by HTLV-I and implications for cell transformation.Oncogene245952–5964.10.1038/sj.onc.1208969
131
SuzukiT.FujisawaJ. I.ToitaM.YoshidaM. (1993a). The transactivator Tax of human T-cell leukemia virus type I (HTLV-I) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-I.Proc. Natl. Acad. Sci. U.S.A.90610–614.10.1073/pnas.90.2.610
132
SuzukiT.HiraiH.FujisawaJ.FujitaT.YoshidaM. (1993b). A trans-activator Tax of human T-cell leukemia virus type 1 binds to NF-kappa B p50 and serum response factor (SRF) and associates with enhancer DNAs of the NF-kappa B site and CArG box.Oncogene82391–2397.
133
SuzukiT.HiraiH.MurakamiT.YoshidaM. (1995). Tax protein of HTLV-1 destabilizes the complexes of NF-κB and IκB-alpha and induces nuclear translocation of NF-κB for transcriptional activation.Oncogene101199–1207.
134
SuzukiT.HiraiH.YoshidaM. (1994). Tax protein of HTLV-1 interacts with the Rel homology domain of NF-kappa B p65 and c-Rel proteins bound to the NF-kappa B binding site and activates transcription.Oncogene93099–3105.
135
SuzukiT.OhsugiY.Uchida-ToitaM.AkiyamaT.YoshidaM. (1999). Tax oncoprotein of HTLV-1 binds to the human homologue of Drosophila discs large tumor suppressor protein, hDLG, and perturbs its function in cell growth control.Oncogene185967–5972.10.1038/sj.onc.1203008
136
SwitzerW. M.QariS. H.WolfeN. D.BurkeD. S.FolksT. M.HeneineW. (2006). Ancient origin and molecular features of the novel human T-lymphotropic virus type 3 revealed by complete genome analysis.J. Virol.807427–7438.10.1128/JVI.00690-06
137
SwitzerW. M.SalemiM.QariS. H.JiaH.GrayR. R.KatzourakisA.et al (2009). Ancient, independent evolution and distinct molecular features of the novel human T-lymphotropic virus type 4.Retrovirology69 10.1186/1742-4690-6-9
138
Tabakin-FixY.AzranI.Schavinky-KhrapunskyY.LevyO.AboudM. (2006). Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications.Carcinogenesis27673–681.10.1093/carcin/bgi274
139
TangH. M.GaoW. W.ChanC. P.SiuY. T.WongC. M.KokK. H.et al (2013a). LKB1 tumor suppressor and salt-inducible kinases negatively regulate human T-cell leukemia virus type 1 transcription.Retrovirology1040 10.1186/1742-4690-10-40
140
TangS. W.ChenC. Y.KlaseZ.ZaneL.JeangK. T. (2013b). The cellular autophagy pathway modulates human T-cell leukemia virus type 1 replication.J. Virol.871699–1707.10.1128/JVI.02147-12
141
TosiG.ForlaniG.AndresenV.TurciM.BertazzoniU.FranchiniG.et al (2011). Major histocompatibility complex class II transactivator CIITA is a viral restriction factor that targets human T-cell lymphotropic virus type 1 Tax-1 function and inhibits viral replication.J. Virol.8510719–10729.10.1128/JVI.00813-11
142
TrippA.BanerjeeP.SieburgM.PlanellesV.LiF.FeuerG. (2005). Induction of cell cycle arrest by human T-cell lymphotropic virus type 1 Tax in hematopoietic progenitor (CD34+) cells: modulation of p21cip1/waf1 and p27kip1 expression.J. Virol.7914069–14078.10.1128/JVI.79.22.14069-14078.2005
143
TrippA.LiuY.SieburgM.MontalbanoJ.WrzesinskiS.FeuerG. (2003). Human T-cell leukemia virus type 1 tax oncoprotein suppression of multilineage hematopoiesis of CD34+ cells in vitro.J. Virol.7712152–12164.10.1128/JVI.77.22.12152-12164.2003
144
TsubataC.HiguchiM.TakahashiM.OieM.TanakaY.GejyoF.et al (2005). PDZ domain-binding motif of human T-cell leukemia virus type 1 Tax oncoprotein is essential for the interleukin 2 independent growth induction of a T-cell line.Retrovirology232–46.10.1186/1742-4690-2-46
145
TurciM.LodewickJ.Di GennaroG.RinaldiA. S.MarinO.DianiE.et al (2012). Ubiquitination and sumoylation of the HTLV-2 Tax-2B protein regulate its NF-κB activity: a comparative study with the HTLV-1 Tax-1 protein.Retrovirology9102 10.1186/1742-4690-9-102
146
TurciM.LodewickJ.RighiP.PolaniaA.RomanelliM. G.BexF.et al (2009). HTLV-2B Tax oncoprotein is modified by ubiquitination and sumoylation and displays intracellular localization similar to its homologue HTLV-1 Tax.Virology3866–11.10.1016/j.virol.2009.01.003
147
TurciM.RomanelliM. G.LorenziP.RighiP.BertazzoniU. (2006a). Localization of human T-cell lymphotropic virus type II Tax protein is dependent upon a nuclear localization determinant in the N-terminal region.Gene365119–124.10.1016/j.gene.2005.09.043
148
TurciM.PilottiE.RonziP.MagnaniG.BoschiniA.ParisiS. G.et al (2006b). Coinfection with HIV-1 and human T-Cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS.J. Acquir. Immune Defic. Syndr.41100–106.10.1097/01.qai.0000179426.04166.12
149
TwizereJ. C.SpringaelJ. Y.BoxusM.BurnyA.DequiedtF.DewulfJ. F.et al (2007). Human T-cell leukemia virus type-1 Tax oncoprotein regulates G-protein signaling.Blood1091051–1060.10.1182/blood-2006-06-026781
150
VandammeA. M. (2000). The Fifth European Workshop on Virus Evolution and Molecular Epidemiology, Leuven, Belgium, 30 August to 4 September 1999.Evolving viruses and virologists. Trends Microbiol.88–10.10.1016/S0966-842X(99)01664-9
151
Van DoorenS.SalemiM.VandammeA. M. (2001). Dating the origin of the African human T-cell lymphotropic virus type-i (HTLV-I) subtypes.Mol. Biol. Evol.18661–671.10.1093/oxfordjournals.molbev.a003846
152
WangD.GuoM. X.HuH. M.ZhaoZ. Z.QiuH. L.ShaoH. J.et al (2008). Human T-cell leukemia virus type 1 oncoprotein tax represses ZNF268 expression through the cAMP-responsive element-binding protein/activating transcription factor pathway.J. Biol. Chem.28316299–16308.10.1074/jbc.M706426200
153
WatanabeT. (2011). Current status of HTLV-1 infection.Int. J. Hematol.94430–434.10.1007/s12185-011-0934-4
154
WolfeN. D.HeneineW.CarrJ. K.GarciaA. D.ShanmugamV.TamoufeU.et al (2005). Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters.Proc. Natl. Acad. Sci. U.S.A.1027994–7999.10.1073/pnas.0501734102
155
WuK.BottazziM. E.de la FuenteC.DengL.GitlinS. D.MaddukuriA.et al (2004). Protein profile of Tax-associated complexes.J. Biol. Chem.279495–508.10.1074/jbc.M310069200
156
WuX.SunS. C. (2007). Retroviral oncoprotein Tax deregulates NF-κB by activating Tak1 and mediating the physical association of Tak1-IKK.EMBO Rep.8510–515.10.1038/sj.embor.7400931
157
WycuffD. R.MarriottS. J. (2005). The HTLV-I Tax oncoprotein: hyper-tasking at the molecular level.Front. Biosci. 10:620–642. 10.2741/1558
158
XiaoG. (2012). NF-kappaB activation: Tax sumoylation is out, but what about Tax ubiquitination?Retrovirology978 10.1186/1742-4690-9-78
159
XieL.YamamotoB.HaoudiA.SemmesO. J.GreenP. L. (2006). PDZ binding motif of HTLV-1 Tax promotes virus-mediated T-cell proliferation in vitro and persistence in vivo.Blood1071980–1988.10.1182/blood-2005-03-1333
160
YamagishiM.NakanoK.MiyakeA.YamochiT.KagamiY.TsutsumiA.et al (2012). Polycomb-mediated loss of miR-31 activates NIK-dependent StateNF-κB pathway in adult T cell leukemia and other cancers.Cancer Cell21121-3510.1016/j.ccr.2011.12.015
161
YamagishiM.WatanabeT. (2012). Molecular hallmarks of adult T cell leukemia.Front. Microbiol. 3:334. 10.3389/fmicb.2012.00334
162
YamamotoK.IshidaT.NakanoK.YamagishiM.YamochiT.TanakaY.et al (2011). SMYD3 interacts with HTLV-1 Tax and regulates subcellular localization of Tax.Cancer Sci.102260–266.10.1111/j.1349-7006.2010.01752.x
163
YasunagaJ.LinF. C.LuX.JeangK. T. (2011). Ubiquitin-specific peptidase 20 targets TRAF6 and human T cell leukemia virus type 1 tax to negatively regulate NF-kappaB signaling.J. Virol.856212–6219.10.1128/JVI.00079-11
164
YasunagaJ.MatsuokaM. (2011). Molecular mechanisms of HTLV-1 infection and pathogenesis.Int. J. Hematol.94435–442.10.1007/s12185-011-0937-1
165
YinM. J.ChristersonL. B.YamamotoY.KwakY. T.XuS.MercurioF.et al (1998). HTLV-I Tax protein binds to MEKK1 to stimulate IkappaB kinase activity and NF-kappaB activation.Cell93875–884.10.1016/S0092-8674(00)81447-6
166
YinM. J.PaulssenE. J.SeelerJ. S.GaynorR. B. (1995). Protein domains involved in both in vivo and in vitro interactions between human T-cell leukemia virus type I tax and CREB.J. Virol.693420–3432.
167
YoshidaM. (2001). Multiple viral strategies of HTLV-1 for dysregulation of cell growth control.Annu. Rev. Immunol.19475–496.10.1146/annurev.immunol.19.1.475
168
YoshidaM. (2010). Molecular approach to human leukemia: isolation and characterization of the first human retrovirus HTLV-1 and its impact on tumorigenesis in adult T-cell leukemia.Proc. Jpn. Acad. Ser. B Phys. Biol. Sci.86117–130.10.2183/pjab.86.117
169
YoshidaM.SatouY.YasunagaJ.FujisawaJ.MatsuokaM. (2008). Transcriptional control of spliced and unspliced human T-cell leukemia virus type 1 bZIP factor (HBZ) gene.J. Virol.829359–9368.10.1128/JVI.00242-08
170
YuQ.MinodaY.YoshidaR.YoshidaH.IhaH.KobayashiT.et al (2008). HTLV-1 Tax-mediated TAK1 activation involves TAB2 adapter protein.Biochem. Biophys. Res. Commun.365189–194.10.1016/j.bbrc.2007.10.172
171
ZaneL.JeangK. T. (2012). The importance of ubiquitination and sumoylation on the transforming activity of HTLV Tax-1 and Tax-2.Retrovirology9103 10.1186/1742-4690-9-103
172
ZaneL.YasunagaJ.MitagamiY.YedavalliV.TangS. W.ChenC. Y.et al (2012). Wip1 and p53 contribute to HTLV-1 Tax-induced tumorigenesis.Retrovirology219–114.10.1186/1742-4690-9-114
173
ZhaoT.MatsuokaM. (2012). HBZ and its roles in HTLV-1 oncogenesis.Front. Microbiol.3:247. 10.3389/fmicb.2012.00247
174
ZhiH.YangL.KuoY. L.HoY. K.ShihH. M.GiamC. Z. (2011). NF-κB hyper-activation by HTLV-1 tax induces cellular senescence, but can be alleviated by the viral anti-sense protein HBZ.PLoS Pathog.7:e1002025. 10.1371/journal.ppat.1002025
Summary
Keywords
HTLV, Tax proteins, signal transduction, NF-κB
Citation
Romanelli MG, Diani E, Bergamo E, Casoli C, Ciminale V, Bex F and Bertazzoni U (2013) Highlights on distinctive structural and functional properties of HTLV Tax proteins. Front. Microbiol. 4:271. doi: 10.3389/fmicb.2013.00271
Received
10 July 2013
Accepted
20 August 2013
Published
09 September 2013
Volume
4 - 2013
Edited by
Akio Adachi, The University of Tokushima Graduate School, Japan
Reviewed by
Jun-ichi Fujisawa, Kansai Medical University, Japan; Makoto Yamagishi, The University of Tokyo, Japan; Yorifumi Satou, Kumamoto University, Japan
Copyright
© Romanelli, Diani, Bergamo, Casoli, Ciminale, Bex and Bertazzoni.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Maria G. Romanelli, Department of Life and Reproduction Sciences, University of Verona, Strada le Grazie 8, 37134 Verona, Italy e-mail: mariagrazia.romanelli@univr.it
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.